These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 36983258)

  • 1. Cognitive Dysfunctions Measured with the MCCB in Deficit and Non-Deficit Schizophrenia.
    Plichta P; Tyburski E; Bielecki M; Mak M; Kucharska-Mazur J; Podwalski P; Rek-Owodziń K; Waszczuk K; Sagan L; Michalczyk A; Misiak B; Samochowiec J
    J Clin Med; 2023 Mar; 12(6):. PubMed ID: 36983258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Executive Functions and Psychopathology Dimensions in Deficit and Non-Deficit Schizophrenia.
    Bielecki M; Tyburski E; Plichta P; Mak M; Kucharska-Mazur J; Podwalski P; Rek-Owodziń K; Waszczuk K; Sagan L; Mueller ST; Michalczyk A; Misiak B; Samochowiec J
    J Clin Med; 2023 Mar; 12(5):. PubMed ID: 36902784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Relationship between Cognitive Functions and Psychopathological Symptoms in First Episode Psychosis and Chronic Schizophrenia.
    Rek-Owodziń K; Tyburski E; Plichta P; Waszczuk K; Bielecki M; Wietrzyński K; Podwalski P; Rudkowski K; Michalczyk A; Grąźlewski T; Sagan L; Kucharska-Mazur J; Samochowiec J; Mak M
    J Clin Med; 2022 May; 11(9):. PubMed ID: 35566742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.
    Houthoofd SA; Morrens M; Sabbe BG
    Clin Ther; 2008 Sep; 30(9):1565-89. PubMed ID: 18840365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurocognitive Impairments in Deficit and Non-Deficit Schizophrenia and Their Relationships with Symptom Dimensions and Other Clinical Variables.
    Yu M; Tang X; Wang X; Zhang X; Zhang X; Sha W; Yao S; Shu N; Zhang X; Zhang Z
    PLoS One; 2015; 10(9):e0138357. PubMed ID: 26381645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlating cognitive functions to symptom domains and insight in Egyptian patients with schizophrenia.
    Khalil AH; El-Meguid MA; Bastawy M; Rabei S; Ali R; Abd Elmoneam MHE
    Int J Soc Psychiatry; 2020 May; 66(3):240-248. PubMed ID: 31928181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eye movement characteristics in male patients with deficit and non-deficit schizophrenia and their relationships with psychiatric symptoms and cognitive function.
    Zhang L; Zhang X; Fang X; Zhou C; Wen L; Pan X; Zhang F; Chen J
    BMC Neurosci; 2021 Nov; 22(1):70. PubMed ID: 34819034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. White Matter Integrity of the Corpus Callosum and Psychopathological Dimensions in Deficit and Non-Deficit Schizophrenia Patients.
    Podwalski P; Tyburski E; Szczygieł K; Waszczuk K; Rek-Owodziń K; Mak M; Plichta P; Bielecki M; Rudkowski K; Kucharska-Mazur J; Andrusewicz W; Misiak B; Szulc A; Michalczyk A; Michałowska S; Sagan L; Samochowiec J
    J Clin Med; 2021 May; 10(11):. PubMed ID: 34063845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [MATRICS consensus cognitive battery--standard for the assessment of cognitive functions in clinical trials in schizophrenia].
    Jedrasik-Styła M; Ciołkiewicz A; Denisiuk M; Linke M; Parnowska D; Gruszka A; Jarema M; Wichniak A
    Psychiatr Pol; 2012; 46(2):261-71. PubMed ID: 23214396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in inflammatory marker profiles and cognitive functioning between deficit and nondeficit schizophrenia.
    Wang D; Wang Y; Chen Y; Yu L; Wu Z; Liu R; Ren J; Fang X; Zhang C
    Front Immunol; 2022; 13():958972. PubMed ID: 36341400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Latent structure of cognition in schizophrenia: a confirmatory factor analysis of the MATRICS Consensus Cognitive Battery (MCCB).
    McCleery A; Green MF; Hellemann GS; Baade LE; Gold JM; Keefe RS; Kern RS; Mesholam-Gately RI; Seidman LJ; Subotnik KL; Ventura J; Nuechterlein KH
    Psychol Med; 2015; 45(12):2657-66. PubMed ID: 25916421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychopathology and Integrity of the Superior Longitudinal Fasciculus in Deficit and Nondeficit Schizophrenia.
    Podwalski P; Tyburski E; Szczygieł K; Rudkowski K; Waszczuk K; Andrusewicz W; Kucharska-Mazur J; Michalczyk A; Mak M; Cyranka K; Misiak B; Sagan L; Samochowiec J
    Brain Sci; 2022 Feb; 12(2):. PubMed ID: 35204030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysfunction of Cognition Patterns Measured by MATRICS Consensus Cognitive Battery (MCCB) among First Episode Schizophrenia Patients and Their Biological Parents.
    Cao A; Shen T; Li H; Wu C; McCabe M; Mellor D; Byrne L; Zhang J; Huang J; Peng D; Xu Y
    Shanghai Arch Psychiatry; 2017 Jun; 29(3):154-160. PubMed ID: 28904510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gender differences measured by the MATRICS consensus cognitive battery in chronic schizophrenia patients.
    Zhang B; Han M; Tan S; De Yang F; Tan Y; Jiang S; Zhang X; Huang XF
    Sci Rep; 2017 Sep; 7(1):11821. PubMed ID: 28928440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Familial aggregation of MATRICS Consensus Cognitive Battery scores in a large sample of outpatients with schizophrenia and their unaffected relatives.
    Mucci A; Galderisi S; Green MF; Nuechterlein K; Rucci P; Gibertoni D; Rossi A; Rocca P; Bertolino A; Bucci P; Hellemann G; Spisto M; Palumbo D; Aguglia E; Amodeo G; Amore M; Bellomo A; Brugnoli R; Carpiniello B; Dell'Osso L; Di Fabio F; di Giannantonio M; Di Lorenzo G; Marchesi C; Monteleone P; Montemagni C; Oldani L; Romano R; Roncone R; Stratta P; Tenconi E; Vita A; Zeppegno P; Maj M;
    Psychol Med; 2018 Jun; 48(8):1359-1366. PubMed ID: 29017620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of the MATRICS consensus cognitive battery (MCCB) to evaluate cognitive deficits in bipolar disorder: A systematic review and meta-analysis.
    Bo Q; Mao Z; Li X; Wang Z; Wang C; Ma X
    PLoS One; 2017; 12(4):e0176212. PubMed ID: 28437438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive performance during the first year of treatment in first-episode schizophrenia: a case-control study.
    Olivier MR; Killian S; Chiliza B; Asmal L; Schoeman R; Oosthuizen PP; Kidd M; Emsley R
    Psychol Med; 2015 Oct; 45(13):2873-83. PubMed ID: 25998030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The MCCB impairment profile in a Spanish sample of patients with schizophrenia: Effects of diagnosis, age, and gender on cognitive functioning.
    Rodriguez-Jimenez R; Dompablo M; Bagney A; Santabárbara J; Aparicio AI; Torio I; Moreno-Ortega M; Lopez-Anton R; Lobo A; Kern RS; Green MF; Jimenez-Arriero MA; Santos JL; Nuechterlein KH; Palomo T
    Schizophr Res; 2015 Dec; 169(1-3):116-120. PubMed ID: 26416441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum BDNF and GDNF in Chinese male patients with deficit schizophrenia and their relationships with neurocognitive dysfunction.
    Tang X; Zhou C; Gao J; Duan W; Yu M; Xiao W; Zhang X; Dong H; Wang X; Zhang X
    BMC Psychiatry; 2019 Aug; 19(1):254. PubMed ID: 31420036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.